Soleno Therapeutics, Inc. (NASDAQ: SLNO) was given a new $105.00 price target on by analysts at UBS Group AG.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at HC Wainwright from $70.00 to $100.00. They now have a "buy" rating on the stock.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Stifel Nicolaus from $74.00 to $108.00. They now have a "buy" rating on the stock.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday? [Yahoo! Finance]